Hi M17xR3. I, like several other holders below, am very positive about the upside on PTX. Two drugs heading into Phase 1b/II clinical trials and licensed technology that is likely heading to Phase III (Cogene-X technology; through license to Transgene). However, I think the timing of the consolidation, just when it was in a steady upward trajectory from 0.4c to 1c, and announcing a CR due in March was just REALLY poor management. Interest in this stock plummeted immediately, as did the SP. At this stage, i'm not too deep in and will slide it in the bottom draw.
All the best M17. I think at 11c (~0.55c pre-consolidation) PTX is still a very good buy. Hopefully news will begin to flow re: trials and maybe even transgene (not big cash reward, but good for future licensing of cogene-x technology).
GLTA SH
PTX Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
